Planning Capital Management Corporation’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.93K Buy
41
+40
+4,000% +$1.88K ﹤0.01% 591
2024
Q2
$55 Buy
+1
New +$55 ﹤0.01% 681